India
US court orders Guardant Health to pay$245 million for cancer patent infringement
A federal judge ordered Guardant Health to pay over $245 million to TwinStrand Biosciences and the University of Washington. This judgment follows a jury verdict for infringing patented DNA sequencing technology. Guardant Health will pay an upfront amount and an ongoing royalty u
Read full story on Times of India →India — TOI TECH DESK

